Epidermal Growth Factor Receptor Inhibition with Erlotinib Partially Prevents Cisplatin-Induced Nephrotoxicity in Rats
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epidermal Growth Factor Receptor Inhibition with Erlotinib Partially Prevents Cisplatin-Induced Nephrotoxicity in Rats
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 11, Pages e111728
Publisher
Public Library of Science (PLoS)
Online
2014-11-13
DOI
10.1371/journal.pone.0111728
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained Activation of EGFR Triggers Renal Fibrogenesis after Acute Kidney Injury
- (2013) Jinhua Tang et al. AMERICAN JOURNAL OF PATHOLOGY
- Cyanidin reverses cisplatin-induced apoptosis in HK-2 proximal tubular cells through inhibition of ROS-mediated DNA damage and modulation of the ERK and AKT pathways
- (2013) Si Gao et al. CANCER LETTERS
- Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial
- (2013) Renato G. Martins et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of epidermal growth factor receptor in acute and chronic kidney injury
- (2013) Jinhua Tang et al. KIDNEY INTERNATIONAL
- Time Courses of Changes in Phospho- and Total- MAP Kinases in the Cochlea after Intense Noise Exposure
- (2013) Yukihide Maeda et al. PLoS One
- 5-Aminolevulinic Acid Protects against Cisplatin-Induced Nephrotoxicity without Compromising the Anticancer Efficiency of Cisplatin in Rats In Vitro and In Vivo
- (2013) Yoshio Terada et al. PLoS One
- Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
- (2012) Libero Santarpia et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
- (2012) In Gyu Hwang et al. INVESTIGATIONAL NEW DRUGS
- Randomized, Phase III Study of Gemcitabine or Erlotinib Maintenance Therapy Versus Observation, With Predefined Second-Line Treatment, After Cisplatin-Gemcitabine Induction Chemotherapy in Advanced Non–Small-Cell Lung Cancer
- (2012) Maurice Pérol et al. JOURNAL OF CLINICAL ONCOLOGY
- Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury
- (2012) Jianchun Chen et al. KIDNEY INTERNATIONAL
- Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats
- (2012) Blanca Humanes et al. KIDNEY INTERNATIONAL
- Epidermal growth factor: a new therapeutic target in glomerular disease
- (2012) M. Flamant et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Combination Erlotinib-Cisplatin and Atg3-Mediated Autophagy in Erlotinib Resistant Lung Cancer
- (2012) Jasmine G. Lee et al. PLoS One
- The Effect of Sildenafil on Cisplatin Nephrotoxicity in Rats
- (2011) Badreldin H. Ali et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Src family kinases regulate renal epithelial dedifferentiation through activation of EGFR/PI3K signaling
- (2011) Shougang Zhuang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Nilotinib Attenuates Renal Injury and Prolongs Survival in Chronic Kidney Disease
- (2011) M. Iyoda et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis
- (2011) Guillaume Bollée et al. NATURE MEDICINE
- Epidermal growth factor activates Na+/H+ exchanger in podocytes through a mechanism that involves Janus kinase and calmodulin
- (2009) Sonya D. Coaxum et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
- (2008) N. Pabla et al. KIDNEY INTERNATIONAL
- The phosphoinositide-3 kinase γ–Akt pathway mediates renal tubular injury in cisplatin nephrotoxicity
- (2007) H. Kuwana et al. KIDNEY INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More